Belgium· BE-AMP-SAM660470-00

Ganirelix Gedeon Richter 0.25 mg/0.5 ml

A ganirelix product containing ganirelix, registered in Belgium by Gedeon Richter. The same ATC class is registered in 17 of our 19 countries.

ATC H01CC01

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about ganirelixAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Ganirelix is registered in 17 of 19 countries.

Countries holding a registration under ATC H01CC01 (ganirelix), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
10 of them publish a price we can compare per daily dose

Search ganirelix products by name

Ganirelix · ATC H01CC01

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Ganirelix
Manufacturer: Gedeon Richter
Country: Belgium (BE)
ATC code: H01CC01
ATC class: Ganirelix
Defined daily dose: 0.25 mg, P
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 2

be_apb
4581088
be_apb
4581096

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

7 interactions on record for ganirelix.

Graded by severity as the source publishes them — 7 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check ganirelix against other medicines How interaction checks work

Ganirelix · interactions on record

7 records

7 moderate

Most severe, free to view

Chorionic gonadotrophinG03GA01moderate
Menotropin HMGG03GA02moderate
UrofollitropinG03GA04moderate
GonadorelinH01CA01moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ganirelix in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ganirelix products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

Austria · Ganirelix Astro, Ganirelix Theramex
Bulgaria · Ganirelix Theramex
Czechia · Fyremadel
Germany · Fyremadel, Ganiran
Denmark · Fyremadel, Ganirelix Orifarm
Estonia · Ganirelix Theramex
Spain · Astarté, Fyremadel
Finland · Fyremadel, Ganirelix Orifarm
France · Fyremadel, Ganirelix Eg
United Kingdom (Northern Ireland) · Fyremadel
Greece · Fyremadel, Ovamex
Croatia · Ganireliks Theramex
Hungary · Ganirelix Theramex
Iceland · Ganirelix, Ganirelix Gedeon Richter
Italy · Fyremadel, Ovamex
Liechtenstein · Ganirelix, Ganirelix Gedeon Richter
Lithuania · Ganirelix Theramex
Latvia · Ganirelix Theramex
Netherlands · Fyremadel, Ganirelix Fagron
Norway · Fyremadel, Ganirelix
Poland · Fyremadel, Ovamex
Portugal · Astarté, Fyremadel
Sweden · Fyremadel, Ganirelix Orifarm
Slovenia · Ganireliks Theramex
Slovakia · Fyremadel, Ganirelix Theramex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/c5a74386-92f8-4212-9356-990f4bd305d7
GET /v1/drugs/c5a74386-92f8-4212-9356-990f4bd305d7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection in pre-filled syringe",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Ganirelix Gedeon Richter 0.25 mg/0.5 ml",
  "name_fr": "Ganirelix Gedeon Richter 0.25 mg/0.5 ml",
  "name_nl": "Ganirelix Gedeon Richter 0.25 mg/0.5 ml",
  "amp_code": "SAM660470-00",
  "strengths": [
    "0.2500",
    "0.2500",
    "0.2500"
  ],
  "pack_count": 3,
  "substances": [
    "Ganirelix",
    "Mannitol",
    "Sodium Hydroxide"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Ganirelix",
  "authorisation_numbers": [
    "EU/1/22/1658/001",
    "EU/1/22/1658/002",
    "EU/1/22/1658/003"
  ]
}

API reference MCP server Plans

See everything about ganirelix.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console